Stalk us here
Powered by Fresh Ideas

Flow Health Science Launches Innovative Hypoglycaemia Treatment Klario

World 27.05.2026
Source: www.foodbev.com
EN 中文 DE FR عربى
Flow Health Science introduces Klario, a new functional beverage designed to improve hypoglycaemia management. The product combines fast-acting carbohydrates with adaptive energy sources, winning Best Health Innovation at the Food Innovation Awards.
Flow Health Science Launches Innovative Hypoglycaemia Treatment Klario

Flow Health Science has launched Klario, a functional beverage aimed at improving the management of hypoglycaemia, which is a common challenge for individuals with diabetes. Klario won Best Health Innovation at the recent Food Innovation Awards, demonstrating its impact in the field.

Klario is designed to go beyond standard glucose-only treatments by combining 15 grams of fast-acting carbohydrates with additional adaptive energy sources. This formulation aims to address not only the immediate need for glucose restoration but also the underlying energy deficit that contributes to symptoms such as fatigue and cognitive impairment after a hypo event.

The development of Klario was inspired by the gap in current hypoglycaemia care. Despite advancements in diabetes technology, such as continuous glucose monitors, the actual treatment of low blood sugar episodes had seen little change over the decades. Klario represents a significant step forward by providing a clinically proven solution that combines consumer product accessibility with pharmaceutical-level scientific rigor.

In clinical studies involving individuals with type 1 diabetes, Klario was shown to improve user experiences compared to traditional glucose treatments. Participants reported faster symptom relief and greater confidence in managing their condition. Objective data from continuous glucose monitors also indicated more stable glucose levels, with fewer repeat lows observed within two hours after treatment.

Flow Health Science's CEO and founder, Georgia Meyers, highlighted the importance of clinical evidence in gaining traction for Klario. The product is positioned as a bridge between functional foods and pharmaceuticals, with a focus on providing robust, peer-reviewed evidence to support its efficacy and safety.

Looking ahead, Flow Health Science plans to expand its product pipeline using the same approach of targeted, evidence-based innovation. The company's long-term vision includes developing products in other health areas such as oncology and endocrinology, aiming to become a leader in clinically proven advanced nutrition.